Stocks
Eisai Co., Ltd.ESALY
OTCHealthcarePharmaceuticals$61.51-2.11%
A Japan-based pharmaceutical company focused on neurology and oncology, with a significant presence in treatments for Alzheimer’s disease and various cancers. Its drug portfolio includes the Alzheimer’s therapy Leqembi, developed in partnership with Biogen, which has drawn global regulatory and reim...
Market Cap: $17.6B52W Range: $36.88 – $73.90
Congressional Interest in Eisai Co., Ltd. (ESALY)
1 member of Congress has disclosed 2 trades in Eisai Co., Ltd. (ESALY), a Healthcare company. The buy/sell breakdown shows 0 purchases versus 2 sales, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
2
Unique Politicians
1
Buys
0
Sells
2
Who in Congress Is Trading ESALY?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2023-01-30 | Daniel Goldman | sell | $1K – $15K |
| 2023-01-13 | Daniel Goldman | sell | $1K – $15K |